Identification of the metabolites of roxithromycin in humans

Drug Metabolism and Disposition

Volumn 28, Issue 5, 2000, Pages 552-559

  Zhong, Dafang ^a   Li, Xueqing ^a   Wang, Aimin ^a   Xu, Youjun ^a   Wu, Shuodong ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ERYTHROMYCIN DERIVATIVE; N NORROXITHROMYCIN; OXIME DERIVATIVE; ROXITHROMYCIN; UNCLASSIFIED DRUG;

ARTICLE; DEALKYLATION; DEMETHYLATION; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERISM; MASS SPECTROMETRY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BILE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MIDDLE AGED; ROXITHROMYCIN;

EID: 0034009447     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Esumi Y, Zin Y, Ban S, Ninomiya S, Hayashi K and Yokoshima T (1988) Absorption, distribution, metabolism and excretion of RU 28965 in animals. Chemother 36 (Suppl 4):148-163.
2. Ferrero JL, Bopp BA, Marsh KC, Quigley SC, Johnson MJ, Anderson DJ, Lamm JE, Tolman KG, Sanders SW, Cavanaugh JH and Sonders RC (1990) Metabolism and disposition of clarithromycin in man. Drug Metab Dispos 18:441-446.
3. Gase C, Gouin DAS, Lutz A and Chantot JF (1991) New ether oxime derivatives of erythromycin A: A structure-activity relationship study. J Antibiot 44:313-330.
4. Gu JK, Zhong DF and Chen XY (1999) Analysis of O-glucuronide conjugates in urine by electrospray ion trap mass spectrometry. Fresenius J Anal Chem 365:553-558.
5. Jarukamjorn K, Thalhammer T, Gollackner B, Pittenauer E and Jager W (1998) Metabolism of roxithromycin in the isolated perfused rat liver. J Pharm Pharmacol 50:515-519.
6. Koyama M, Tateno M, Shirotsuka M, Yamamoto T, Hirayama M, Saitoh K and Okui K (1988) Absorption, metabolism and excretion of RU 28965 in humans. Chemother 36 (Suppl 4):164-183.
7. Markham A and Faulds D (1994) Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 48:297-326.
8. McLean A, Sutton JA, Salmon J and Chatelet D (1988) Roxithromycin: Pharmacokinetic and metabolism study in humans. Br J Clin Pract 42 (Suppl 55):52-53.
9. Shirotsuka M, Yamamoto T, Hirayama M, Saitoh K and Okui K (1988) High-performance liquid chromatography of RU 28965 and its metabolites in body fluids. Chemother 36 (Suppl 4):138-147.
10. Young A, Gonzalez JP and Sorkin EM (1989) Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37:8-41.